Tag: NAVB
Stocks to Trade

Navidea Biopharmaceuticals, Inc. (NAVB) Stock Surged 25.28% Pre-Market, Here’s Why

Navidea Biopharmaceuticals, Inc. (NAVB) stock soared 25.58% in the pre-market trading session at the price of $1.11 following the regulatory approval of Lymphoaim in India.   NAVB is a biopharmaceutical firm centered on the production of innovative immuno-diagnostic agents. The company is devising numerous precision-targeted

Stocks Register is a comprehensive online news hub delivering daily updates on various facets of U.S. life, including business, technology, politics, economy, culture, sports, and noteworthy global events.

Quick Links
Categories
All rights reserved ©2024, Powered by Smart TechOne
Stocks Register
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.